Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A. 1993. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Research 53(6):1304–1311.
Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. 1997. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. American Journal of Epidemiology 146(8):609–617.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
2 Testosterone and Health Outcomes ."
Testosterone and Aging: Clinical Research Directions . Washington, DC: The National Academies Press,
Please select a format: